TNF-α converting enzyme (TACE) as a therapeutic target

被引：34

作者：

Skotnicki, JS ^{[1
]}

Levin, JI ^{[1
]}

机构：

[1] Wyeth Ayerst Res, Pearl River, NY 10965 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38 | 2003年 / 38卷

关键词：

D O I：

10.1016/S0065-7743(03)38017-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：153 / 162

页数：10

共 50 条

[1] TNF-α converting enzyme (TACE) is inhibited by TIMP-3
Amour, A
Slocombe, PM
Webster, A
Butler, M
Knight, CG
Smith, BJ
Stephens, PE
Shelley, C
Hutton, M
Knäuper, V
Docherty, AJP
Murphy, G
[J]. FEBS LETTERS, 1998, 435 (01) : 39 - 44
[2] Adamalysins -: A family of metzincins including TNF-α converting enzyme (TACE)
Killar, L
White, J
Black, R
Peschon, J
[J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 442 - 452
[3] TNF-α-converting enzyme (TACE) expression in human and rat tissue.
Knabb, MT
Solomon, KA
Reilly, TM
Corjay, MH
[J]. FASEB JOURNAL, 1999, 13 (04): : A204 - A204
[4] DETERMINANTS FOR PRODOMAIN INHIBITION OF THE TNF-α CONVERTING ENZYME (TACE) ZYMOGEN STATE
Milla, Marcos E.
[J]. ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 719 - 720
[5] The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors
Rosner, Kristin E.
Guo, Zhuyan
Orth, Peter
Shipps, Gerald W., Jr.
Belanger, David B.
Chan, Tin Yau
Curran, Patrick J.
Dai, Chaoyang
Deng, Yongqi
Girijavallabhan, Vinay M.
Hong, Liwu
Lavey, Brian J.
Lee, Joe F.
Li, Dansu
Liu, Zhidan
Popovici-Muller, Janeta
Ting, Pauline C.
Vaccaro, Henry
Wang, Li
Wang, Tong
Yu, Wensheng
Zhou, Guowei
Niu, Xiaoda
Sun, Jing
Kozlowski, Joseph A.
Lundell, Daniel J.
Madison, Vincent
McKittrick, Brian
Piwinski, John J.
Shih, Neng -Yang
Siddiqui, M. Arshad
Strickland, Corey O.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1189 - 1193
[6] Synthesis of piperidine phenyl sulfone hydroxamates as TACE (TNF-α converting enzyme) inhibitors
Park, K
Levin, JI
Aplasca, A
Du, ML
Lovering, FE
Condon, JS
Zhang, YH
Sun, LH
Zhu, Y
Xu, WX
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U151 - U152
[7] Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases
Girijavallabhan, Vinay M.
Chen, Lei
Dai, Chaoyang
Feltz, Robert J.
Firmansjah, Luke
Li, Dansu
Kim, Seong Heon
Kozlowski, Joseph A.
Lavey, Brian J.
Kosinski, Aneta
Piwinski, John J.
Popovici-Muller, Janeta
Rizvi, Razia
Rosner, Kristin E.
Shankar, Banderpalle B.
Shih, Neng-Yang
Siddiqui, M. Arshad
Tong, Ling
Wong, Michael K. C.
Yang, De-yi
Yang, Liping
Yu, Wensheng
Zhou, Guowei
Guo, Zhuyan
Orth, Peter
Madison, Vincent
Bian, Hong
Lundell, Daniel
Niu, Xiaoda
Shah, Himanshu
Sun, Jing
Umland, Shelby
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7283 - 7287
[8] The mechanism by which cannabidiol (CBD) suppresses TNF-α secretion involves inappropriate localization of TNF-α converting enzyme (TACE)
Frodella, Christa M.
Liu, Liyuan
Tan, Wei
Pruett, Stephen B.
Kaplan, Barbara L. F.
[J]. CELLULAR IMMUNOLOGY, 2024, 397
[9] TNF-α converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis
Comabella, Manuel
Romera, Cristina
Camina, Montse
Perkal, Hector
Moro, Maria A.
Leza, Juan C.
Lizasoain, Ignacio
Castillo, Mireia
Montalban, Xavier
[J]. JOURNAL OF NEUROLOGY, 2006, 253 (06) : 701 - 706
[10] Design, synthesis and evaluation of β-benzamido hydroxamic acid inhibitors of TNF-α converting enzyme (TACE).
Ott, GR
Lu, ZH
Asakawa, N
Covington, MB
Qian, MX
Liu, RQ
Newton, RC
Christ, DD
Decicco, CP
Duan, JJW
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U966 - U966

← 1 2 3 4 5 →